Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $758.55 | 16 | 95.2% |
| Education | $38.00 | 1 | 4.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $514.78 | 5 | $0 (2019) |
| Genentech USA, Inc. | $155.78 | 3 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $57.79 | 7 | $0 (2017) |
| Mylan Specialty L.P. | $49.00 | 1 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.20 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $73.82 | 3 | Genentech USA, Inc. ($55.67) |
| 2018 | $168.31 | 3 | Genentech USA, Inc. ($100.11) |
| 2017 | $554.42 | 11 | GlaxoSmithKline, LLC. ($496.63) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2019 | Genentech USA, Inc. | Esbriet (Biological) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: Immunology | ||||||
| 02/25/2019 | Genentech USA, Inc. | Esbriet (Biological) | Education | In-kind items and services | $38.00 | General |
| Category: Immunology | ||||||
| 10/15/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $19.20 | General |
| 10/09/2018 | Mylan Specialty L.P. | — | Food and Beverage | In-kind items and services | $49.00 | General |
| 08/21/2018 | Genentech USA, Inc. | Esbriet (Biological) | Food and Beverage | In-kind items and services | $100.11 | General |
| Category: Immunology | ||||||
| 12/06/2017 | GlaxoSmithKline, LLC. | INCRUSE (Drug) | Food and Beverage | In-kind items and services | $98.13 | General |
| Category: RESPIRATORY | ||||||
| 08/18/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: RESPIRATORY | ||||||
| 08/18/2017 | Sunovion Pharmaceuticals Inc. | BROVANA (Drug) | Food and Beverage | In-kind items and services | $7.13 | General |
| Category: RESPIRATORY | ||||||
| 07/14/2017 | Sunovion Pharmaceuticals Inc. | BROVANA (Drug) | Food and Beverage | In-kind items and services | $5.62 | General |
| Category: RESPIRATORY | ||||||
| 06/16/2017 | Sunovion Pharmaceuticals Inc. | BROVANA (Drug) | Food and Beverage | In-kind items and services | $9.21 | General |
| Category: RESPIRATORY | ||||||
| 06/16/2017 | Sunovion Pharmaceuticals Inc. | BROVANA (Drug) | Food and Beverage | In-kind items and services | $7.95 | General |
| Category: RESPIRATORY | ||||||
| 05/11/2017 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RESPIRATORY | ||||||
| 05/10/2017 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $3.38 | General |
| Category: RESPIRATORY | ||||||
| 05/09/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Food and Beverage | In-kind items and services | $6.95 | General |
| Category: RESPIRATORY | ||||||
| 03/01/2017 | Sunovion Pharmaceuticals Inc. | BROVANA (Drug) | Food and Beverage | In-kind items and services | $6.50 | General |
| Category: RESPIRATORY | ||||||
| 01/11/2017 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $270.12 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 297 | 297 | $43,710 | $6,127 |
| 2022 | 8 | 310 | 311 | $84,984 | $13,227 |
| 2021 | 8 | 359 | 372 | $172,305 | $26,630 |
| 2020 | 15 | 726 | 758 | $275,672 | $45,748 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 15 | 15 | $16,500 | $1,973 | 12.0% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 17 | 17 | $3,910 | $1,090 | 27.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 21 | 21 | $3,171 | $940.19 | 29.6% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 79 | 79 | $4,740 | $823.04 | 17.4% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 81 | 81 | $7,533 | $628.63 | 8.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 41 | 41 | $4,674 | $351.36 | 7.5% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 43 | 43 | $3,182 | $321.16 | 10.1% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2022 | 37 | 37 | $40,700 | $4,776 | 11.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 66 | 66 | $15,180 | $3,879 | 25.6% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2022 | 12 | 12 | $12,000 | $1,469 | 12.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 27 | 28 | $4,228 | $1,357 | 32.1% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 53 | 53 | $3,021 | $673.73 | 22.3% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 56 | 56 | $4,984 | $527.07 | 10.6% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2022 | 40 | 40 | $2,800 | $327.72 | 11.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 19 | 19 | $2,071 | $218.84 | 10.6% |
| 95811 | Sleep monitoring of patient (6 years or older) in sleep lab with continued pressured respiratory assistance by mask or breathing tube | Office | 2021 | 79 | 82 | $90,200 | $11,308 | 12.5% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 99 | 99 | $22,770 | $6,300 | 27.7% |
| 95810 | Sleep monitoring of patient (6 years or older) in sleep lab | Office | 2021 | 41 | 41 | $41,000 | $5,259 | 12.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 50 | 60 | $9,060 | $2,799 | 30.9% |
| 94726 | Determination of lung volumes using plethysmography | Facility | 2021 | 28 | 28 | $1,617 | $365.30 | 22.6% |
| 94729 | Measurement of lung diffusing capacity | Facility | 2021 | 30 | 30 | $1,589 | $290.05 | 18.3% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Facility | 2021 | 20 | 20 | $2,791 | $186.00 | 6.7% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Facility | 2021 | 12 | 12 | $3,278 | $123.93 | 3.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 120 | 136 | $69,360 | $12,550 | 18.1% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 39 | 39 | $38,142 | $6,242 | 16.4% |
About Dr. Beth Baker, MD
Dr. Beth Baker, MD is a Pulmonary Disease healthcare provider based in Anchorage, Alaska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1184606956.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Beth Baker, MD has received a total of $796.55 in payments from pharmaceutical and medical device companies, with $73.82 received in 2019. These payments were reported across 17 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($758.55).
As a Medicare-enrolled provider, Baker has provided services to 1,692 Medicare beneficiaries, totaling 1,738 services with total Medicare billing of $91,733. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Location Anchorage, AK
- Active Since 11/17/2005
- Last Updated 08/03/2018
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1184606956
Products in Payments
- Esbriet (Biological) $155.78
- ANORO ELLIPTA (Drug) $125.00
- INCRUSE (Drug) $98.13
- BROVANA (Drug) $36.41
- UTIBRON (Drug) $21.38
- NUCALA (Biological) $18.15
- ANORO (Drug) $3.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Anchorage
Marek Martynowicz, Md, MD
Pulmonary Disease — Payments: $13,937
John Clark, Md, MD
Pulmonary Disease — Payments: $1,122
Gregory Gerboth, Md, MD
Pulmonary Disease — Payments: $754.41
Denise Wurth, Md, MD
Pulmonary Disease — Payments: $421.14
David Zielke, Md, MD
Pulmonary Disease — Payments: $120.58
Dr. David Frankl, M.d., M.p.h, M.D., M.P.H
Pulmonary Disease — Payments: $67.76